Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-046710

CEO and Chairman sold 1,501 shares at $38.24 ($57,398)

From the SEC's structured data for this filing

Trades in this filing

ROBINS CHAD M · CEO and Chairman

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-07-12 Sale : show line 1 in the form −1,501 $38.24 $57,398 1,716,960 D
Open-market sales · 1,501 sh · avg $38.24 · $57,398
Loading xslF345X03/doc4.xml…